Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Acrux Limited ( (AU:ACR) ) has shared an announcement.
Acrux Limited has announced the issuance of 3,714,284 fully paid ordinary shares to Directors as part of a previously approved Share Placement and Share Purchase Plan. This move aligns with the company’s efforts to strengthen its financial position and support its operations in the specialty pharmaceutical industry, with no excluded information required to be disclosed under the Corporations Act.
More about Acrux Limited
Acrux is a specialty pharma company known for developing and commercializing topically applied pharmaceutical products. With a 25-year history, the company has successfully marketed products globally, focusing on the United States. Acrux leverages its experienced workforce, laboratories, and manufacturing capabilities to develop affordable topical generic products and actively seeks commercial partnerships and product development opportunities.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.86M
For an in-depth examination of ACR stock, go to TipRanks’ Stock Analysis page.
